2022
DOI: 10.1155/2022/3838126
|View full text |Cite
|
Sign up to set email alerts
|

Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis

Abstract: Objective. Postmenopausal women experiences osteoporotic structural damage and bone fragility resulting from reduced bone formation and increased bone resorption. Osteoporosis frequently affects the vertebral column and causes compression fractures. This study aims to characterize roles of miRNAs in osteoporosis and subsequent incidence risk of vertebral fractures for postmenopausal women. Methods. Differentially expressed miRNAs between osteoporotic patients with vertebral fractures and osteoporotic patients … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 34 publications
0
3
0
Order By: Relevance
“…miRNAs have the ability to post-transcriptionally regulate and silence target gene expression and thus play osteoclast differentiation and survival, as well as osteoblast-to-osteoclast communication [ 10 ]. For example, two miRNAs, miR-485-3p and miR-491-5p, were reported to protect osteoporotic postmenopausal women against vertebral fractures [ 11 ]. miR-340-5p is localized in 5q35 and has been demonstrated to target many genes, such as ROCK1, FHL2, and SKP2, and to regulate the relevant mechanisms involving several signaling pathways, such as JAK-STAT, and Wnt/ β -catenin pathways, thus contributing to in the initiation of several diseases [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…miRNAs have the ability to post-transcriptionally regulate and silence target gene expression and thus play osteoclast differentiation and survival, as well as osteoblast-to-osteoclast communication [ 10 ]. For example, two miRNAs, miR-485-3p and miR-491-5p, were reported to protect osteoporotic postmenopausal women against vertebral fractures [ 11 ]. miR-340-5p is localized in 5q35 and has been demonstrated to target many genes, such as ROCK1, FHL2, and SKP2, and to regulate the relevant mechanisms involving several signaling pathways, such as JAK-STAT, and Wnt/ β -catenin pathways, thus contributing to in the initiation of several diseases [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…We analyzed the literature to identify microRNAs with high potential for use as diagnostic markers of osteoporosis, which may also serve as a basis for the development of oligonucleotide therapeutic approaches in the future (Table 4, Ref. [13,78,87,104,106,119,121,[135][136][137][138][139][140][141][142][143][144][145][146][147][148][149][150][151][152][153]).…”
Section: Clinical Potential Of Micrornas For the Treatment Of Osteopo...mentioning
confidence: 99%
“…Another study found that miR-92a-3p delivered by MSC-derived Exos facilitated cartilage repair, thereby delaying OA progression [ 13 ]. miR-485-3p is expressed at low levels in osteoporotic postmenopausal women and has a close correlation with vertebral fractures [ 14 ]. More importantly, miR-485-3p could promote proliferation and suppress apoptosis of osteoarthritic chondrocytes [ 15 ].…”
Section: Introductionmentioning
confidence: 99%